Medicare expects to spend $3.5B on new Alzheimer's drug in 2025

By STAT News
| April 11, 2024

Medicare's actuaries expect the drug Leqembi to cost the traditional Medicare program around $550 million in 2024 and the entire Medicare program $3.5 billion in 2025.

Full story

#1

Recent research on Paxlovid shows there is "solid data on its effectiveness," a co-author of the study told HealthLeaders. ...

A new personal protective equipment manufacturing company is set to open in Cincinnati next year. ...